Stanbic doubles funding for cancer patients
Full story
Stanbic increased its funding for cancer patients to double the previous amount. The contribution was US$25,000 in 2025. This support is part of a partnership that has lasted for over a decade. The funds aim to reduce the financial strain cancer treatment puts on patients and their families.
The contribution, increased from US$25 000 in 2025, strengthens a partnership spanning more than a decade and supports efforts to ease the financial burden of cancer treatment on patients and their families. The post Stanbic doubles funding for cancer patients appeared first on Newsday .